Evidence map›Paper›PMID 29269526›Full record

ArticleHaematologica2018

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.

Nicolas Vallet, Flore Sicre de Fontbrune, Michaël Loschi, Deborah Desmier, Alban Villate, Fiorenza Barraco, Patrice Chevallier, Louis Terriou, Ibrahim Yakoub-Agha, Annalisa Ruggeri and 14 more

Open access · goldAbstract readLetterMulticenter Study
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Eculizumab Bridging before Bone Marrow Transplant for Marrow Failure Disorders Is Safe and Does Not Limit Engraftment.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2018
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 1 country.

Nicolas ValletHematology Department, Tours, France.
Flore Sicre de FontbruneHematology Department, Saint Louis Hospital, Paris, France.
Michaël LoschiHematology Department, Rouen, France.
Deborah DesmierHematology Department, Poitiers, France.
Alban VillateHematology Department, Tours, France.
Fiorenza BarracoHematology Department, Lyon, France.
Patrice ChevallierHematology Department, Nantes, France.
Louis TerriouHematology Department, Lille, France.
Ibrahim Yakoub-AghaHematology Department, Lille, France.
Annalisa RuggeriHematology Department, Saint Antoine Hospital, Paris, France.
Mohamad MohtyHematology Department, Saint Antoine Hospital, Paris, France.
Natacha MaillardHematology Department, Poitiers, France.
Pierre-Simon RohrlichHematology Department, Nice, France.
Patrice CeballosHematology Department, Montpellier, France.
Stéphanie NguyenHematology Department, Pitié Salpêtrière Hospital, Paris, France.
Xavier PoiréHematology Department, Brussels, Belgium.
Gaëlle GuillermHematology Department, Brest, France.
Reza TabriziHematology Department, Bordeaux, France.
Jonathan FarhiHematology Department, Angers, France.
Raynier DevillierHematology Department, Institut Paoli Calmette, Marseille, France.
Marie-Thérèse RubioHematology Department, Nancy, France.
Gérard SociéHematology Department, Saint Louis Hospital, Paris, France.
Régis Peffault de LatourHematology Department, Saint Louis Hospital, Paris, France regis.peffaultdelatour@aphp.fr.
Société Francophone de Greffe de Moelle et Thérapie Cellulaire
Hôpital Saint-Louis · FRHôpital Saint-Antoine · FRLille’s Cardiology Hospital · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire de Montpellier · FRInstitut Paoli-Calmettes · FRLaboratoire de Thermique et Energie de Nantes · FRPitié-Salpêtrière Hospital · FRUniversité de Rouen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAntibodies, Monoclonal, HumanizedHematopoietic Stem Cell TransplantationHemoglobinuria, ParoxysmalHumansMiddle AgedRegistriesRetrospective StudiesYoung AdultAntibodies, Monoclonal, Humanizedeculizumab

Identifiers

PMID29269526
PMCPMC5830366
OpenAlexW2777564393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.